FinTrust Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$35K Hold
324
0.01% 679
2024
Q2
$35.2K Buy
324
+100
+45% +$11.8K 0.01% 639
2024
Q1
$29.6K Sell
224
-54
-19% -$6.75K 0.01% 662
2023
Q4
$33.8K Hold
278
0.01% 588
2023
Q3
$31.2K Buy
278
+25
+10% +$3.17K 0.01% 558
2023
Q2
$32.3K Hold
253
0.01% 531
2023
Q1
$32.3K Hold
253
0.01% 530
2022
Q4
$32.3K Sell
253
-2
-0.8% -$232 0.01% 529
2022
Q3
$28K Hold
255
0.01% 646
2022
Q2
$27K Hold
255
0.01% 660
2022
Q1
$33K Sell
255
-8
-3% -$964 0.01% 640
2021
Q4
$32K Hold
263
0.01% 627
2021
Q3
$37K Hold
263
0.01% 609
2021
Q2
$41K Hold
263
0.01% 595
2021
Q1
$41K Buy
263
+137
+109% +$21.2K 0.01% 572
2020
Q4
$19K Hold
126
0.01% 701
2020
Q3
$17 Hold
126
﹤0.01% 697
2020
Q2
$15K Hold
126
0.01% 679
2020
Q1
$12K Hold
126
0.01% 726
2019
Q4
$18K Hold
126
0.01% 662
2019
Q3
$17K Hold
126
0.01% 677
2019
Q2
$14K Sell
126
-100
-44% -$11.7K 0.01% 675
2019
Q1
$28K Sell
226
-902
-80% -$103K 0.01% 517
2018
Q4
$114K Buy
+1,128
New +$127K 0.06% 249

Other funds holding ZBH

FinTrust Capital Advisors's ZBH Position: Q3 2024 in Review

FinTrust Capital Advisors held its Zimmer Biomet (ZBH) position steady in Q3 2024 at 324 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #679.

FinTrust Capital Advisors first reported a position in ZBH in Q4 2018 and has held it in 24 quarters since. The position peaked at $114K in Q4 2018. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • FinTrust Capital Advisors held 324 shares of Zimmer Biomet worth $35K as of Q3 2024.
  • FinTrust Capital Advisors left its Zimmer Biomet share count unchanged in Q3 2024.
  • Zimmer Biomet made up 0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #679 holding.
  • FinTrust Capital Advisors first reported a position in Zimmer Biomet in Q4 2018 and has held it in 24 quarters since.
  • FinTrust Capital Advisors's Zimmer Biomet position peaked at $114K in Q4 2018.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.